Search for Clinical Trial Results

Sponsored By

Leukemia, Biphenotypic, Acute - 18 Studies Found

Status Study
Terminated Study Name: Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Condition:
  • Mixed Lineage Acute Leukemia
  • Acute Myeloid Leukemia
  • Date: 2015-04-14
    Interventions:
    • Drug: Bortezomib Bortezomib wi
Recruiting Study Name: GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia
Condition:
  • Leukemia, Acute Lymphoblastic
  • Acute Myeloid Leukemia
  • Date: 2016-06-09
    Interventions:
    • Procedure: Allogeneic stem cell transplantation

Terminated Study Name: Acute Lymphoblastic Leukemia Registry at Asan Medical Center
Condition:
  • Leukemia, Acute Lymphoblastic
  • Precursor B-Cell Lymphoblastic Leukemia
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia
  • Date: 2016-03-14
    Interventions:
    • Drug: Cladribine Given IV
Active, not recruiting Study Name: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
Condition:
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia
  • Date: 2013-03-01
    Interventions:
    • Other: Laboratory Biomarker Analysis

Recruiting Study Name: Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Condition:
  • Acute Biphenotypic Leukemia
  • de Novo Myelodysplastic Syndrome Date: 2014-01-22
    Interventions:
    • Drug: Cladribine Given IV
Recruiting Study Name: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes
Condition:
  • Acute Biphenotypic Leukemia
  • Acute Erythroid Leukemia
  • Date: 2012-09-19
    Interventions:
    • Drug: Cyclophosphamide Given I
Recruiting Study Name: Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Condition:
  • Acute Biphenotypic Leukemia
  • Acute Erythroid Leukemia in Remissi
    Date: 2009-12-08
    Interventions:
    • Drug: Cyclophosphamide Given I
Recruiting Study Name: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant
Condition:
  • Acute Biphenotypic Leukemia
  • Adult Acute Lymphoblastic Leukemia
    Date: 2008-11-21
    Interventions:
    • Drug: Cyclosporine Given IV or
Recruiting Study Name: Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease
Condition:
  • Acute Biphenotypic Leukemia
  • Acute Myeloid Leukemia Arising From
    Date: 2008-07-19
    Interventions:
    • Drug: Cyclophosphamide Given I
Next >>>